Cargando…
Biomarkers for personalised treatment in psychiatric diseases
Biomarker research of psychiatric disorders is delayed by symptom pattern-related diagnostic categories that are only distantly associated with biological mechanisms. In neuropsychiatric disorders that have high heritability (schizophrenia, autism, Alzheimer's disease), genomic research led to...
Autores principales: | Bagdy, Gyorgy, Juhasz, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa UK, Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786517/ https://www.ncbi.nlm.nih.gov/pubmed/23875948 http://dx.doi.org/10.1517/17530059.2013.821979 |
Ejemplares similares
-
Catenin Alpha 2 May Be a Biomarker or Potential Drug Target in Psychiatric Disorders with Perseverative Negative Thinking
por: Eszlari, Nora, et al.
Publicado: (2021) -
New Horizons for Personalised Treatment in Gastroesophageal Cancer
por: Salati, Massimiliano, et al.
Publicado: (2022) -
JOCR: Personalised Journal, Personalised Network and Clinical Decision Making (CDM)
por: Shyam, Ashok
Publicado: (2012) -
Antidepressant treatment response is modulated by genetic and environmental factors and their interactions
por: Kovacs, Dávid, et al.
Publicado: (2014) -
Downregulation of the Vitamin D Receptor Regulated Gene Set in the Hippocampus After MDMA Treatment
por: Petschner, Peter, et al.
Publicado: (2018)